4//SEC Filing
Litchman Manuel MD 4
Accession 0001104659-21-119384
CIK 0001680048other
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 5:23 PM ET
Size
5.2 KB
Accession
0001104659-21-119384
Insider Transaction Report
Form 4
Litchman Manuel MD
DirectorPresident, CEO and Interim CFO
Transactions
- Award
COMMON STOCK
2021-08-31$2.58/sh+2,746$7,085→ 962,987 total
Footnotes (2)
- [F1]These shares were acquired under the Mustang Bio, Inc. Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on March 1, 2021 and ending on August 31, 2021 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's ordinary shares on August 31, 2021 (the purchase date of the offering period).
- [F2]Includes restricted stock units, which vest over various time periods.
Documents
Issuer
MUSTANG BIO, INC.
CIK 0001680048
Entity typeother
Related Parties
1- filerCIK 0001709485
Filing Metadata
- Form type
- 4
- Filed
- Sep 23, 8:00 PM ET
- Accepted
- Sep 24, 5:23 PM ET
- Size
- 5.2 KB